These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11075806)

  • 1. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation.
    Gereben B; Goncalves C; Harney JW; Larsen PR; Bianco AC
    Mol Endocrinol; 2000 Nov; 14(11):1697-708. PubMed ID: 11075806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center.
    Steinsapir J; Bianco AC; Buettner C; Harney J; Larsen PR
    Endocrinology; 2000 Mar; 141(3):1127-35. PubMed ID: 10698189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase.
    Botero D; Gereben B; Goncalves C; De Jesus LA; Harney JW; Bianco AC
    Mol Endocrinol; 2002 Sep; 16(9):1999-2007. PubMed ID: 12198238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.
    Steinsapir J; Harney J; Larsen PR
    J Clin Invest; 1998 Dec; 102(11):1895-9. PubMed ID: 9835613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation.
    Curcio-Morelli C; Zavacki AM; Christofollete M; Gereben B; de Freitas BC; Harney JW; Li Z; Wu G; Bianco AC
    J Clin Invest; 2003 Jul; 112(2):189-96. PubMed ID: 12865408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress decreases intracellular thyroid hormone activation via an eIF2a-mediated decrease in type 2 deiodinase synthesis.
    Arrojo E Drigo R; Fonseca TL; Castillo M; Salathe M; Simovic G; Mohácsik P; Gereben B; Bianco AC
    Mol Endocrinol; 2011 Dec; 25(12):2065-75. PubMed ID: 22053000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
    de Virgilio M; Weninger H; Ivessa NE
    J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 deiodinase at the crossroads of thyroid hormone action.
    Arrojo E Drigo R; Bianco AC
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1432-41. PubMed ID: 21679772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2.
    Kim BW; Zavacki AM; Curcio-Morelli C; Dentice M; Harney JW; Larsen PR; Bianco AC
    Mol Endocrinol; 2003 Dec; 17(12):2603-12. PubMed ID: 12933904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase.
    Zavacki AM; Arrojo E Drigo R; Freitas BC; Chung M; Harney JW; Egri P; Wittmann G; Fekete C; Gereben B; Bianco AC
    Mol Cell Biol; 2009 Oct; 29(19):5339-47. PubMed ID: 19651899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling.
    Arrojo E Drigo R; Fonseca TL; Werneck-de-Castro JP; Bianco AC
    Biochim Biophys Acta; 2013 Jul; 1830(7):3956-64. PubMed ID: 22967761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and structural biology of the deiodinases.
    Bianco AC; Larsen PR
    Thyroid; 2005 Aug; 15(8):777-86. PubMed ID: 16131321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
    Werneck de Castro JP; Fonseca TL; Ueta CB; McAninch EA; Abdalla S; Wittmann G; Lechan RM; Gereben B; Bianco AC
    J Clin Invest; 2015 Feb; 125(2):769-81. PubMed ID: 25555216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation.
    Bays NW; Gardner RG; Seelig LP; Joazeiro CA; Hampton RY
    Nat Cell Biol; 2001 Jan; 3(1):24-9. PubMed ID: 11146622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modes of regulation of ubiquitin-mediated protein degradation.
    Kornitzer D; Ciechanover A
    J Cell Physiol; 2000 Jan; 182(1):1-11. PubMed ID: 10567911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal requirements for ubiquitination-mediated regulation of thyroid hormone activation.
    Egri P; Gereben B
    J Mol Endocrinol; 2014 Oct; 53(2):217-26. PubMed ID: 25074266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-mediated protein modification and degradation.
    Schwartz AL; Ciechanover A
    Am J Respir Cell Mol Biol; 1992 Nov; 7(5):463-8. PubMed ID: 1329865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.
    Maia AL; Kim BW; Huang SA; Harney JW; Larsen PR
    J Clin Invest; 2005 Sep; 115(9):2524-33. PubMed ID: 16127464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
    Borges M; Ingbar SH; Silva JE
    Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast.
    Kuiper GG; Klootwijk W; Visser TJ
    J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.